Twitter Facebook LinkedIn YouTube

THC BioMed Intl Ltd. (CSE: THC) New Listing

Video Platform Video Management Video Solutions Video Player

The company has two Licensed Producer applications being evaluated by Health Canada under the Marihuana for Medical Purposes Regulations, with one filed for each of the company’s wholly-owned subsidiaries.

Additional Information:

Company: THC BioMed Intl Ltd.
Website: http://thcbiomed.com/
Stock Symbol: THC BioMed Intl Ltd.
Date Published: Apr 30, 2015
Transcript: Available

Video Transcript:

I’m Samantha Deutscher for Investmentpitch Media

THC BioMed Intl Ltd is one of the latest new listings on the Canadian Securities Exchange, and is trading under the symbol “THC”.

The company has two Licensed Producer applications being evaluated by Health Canada under the Marihuana for Medical Purposes Regulations, with one filed for each of the company’s wholly-owned subsidiaries.

Its Kelowna-based THC BioMed Ltd subsidiary is at an advanced stage of the Health Canada MMPR application process, with Health Canada’s Pre-License inspection completed.

Having reached the 7th and final stage with this application, the next step, if the application is approved, would be the granting of an MMPR License by Health Canada.

This would allow the company to produce marijuana but not sell it to the public until it has graduated to a “Fully Authorized Licensed Producer” status, at which time it would be able to sell its product to eligible persons under the MMPR.

The company also provides consulting services to aspiring MMPR Licensed Producers and to those already in possession of their license that are seeking guidance through the graduated licensing process from the cultivation stage to becoming fully authorized Licensed Producers.

The company plans to develop other products and services for MMPR Licensed producers, focusing on medical cannabis research & development, plant innovation and life sciences.

The shares are currently bid at $0.10 and have 76 million shares outstanding.

For more information, please visit the company’s website www.thcbiomed.com or contact John Miller, President & CEO, at 604-682-1643 or email info@thcbiomed.com.

I’m Samantha Deutscher for Investmentpitch Media
For more video news, and to view our disclaimer, please visit our website at www.investmentpitch.com and to receive our latest videos, please sign up for our RSS feed.
This video is for information purposes only and it not a recommendation to buy or sell any securities.